No Longer Enrolling

Clinical TrialStudy Result Published
A4 Study
3-year prevention trial


ASCEND
2-year study of cardiovascular influences on AD


Atomoxetine Clinical Trial:
for people with Mild Cognitive Impairment (MCI)

Neuroimaging & Biomarkers Study - ADNI: Normal Aging, Mild Cognitive Impairment & Early Alzheimer's Disease

Over 100 Study publications
http://www.ncbi.nlm.nih.gov/pubmed?term=ADNI

Racial Disparities in ADL's

Results pending

Registry for Remembrance
An initiative to increase awareness & participation in neurology research


DIAN Study
2-year prevention trial


Right Frontal Activity in Older Adults: Does it Help or Hurt Word Retrieval?


Effects of Perceptual Interference on Memory in Mild Cognitive Impairment (MCI)


The Tele-Savvy Program
A 6 week on-line education & training program for persons caring for a family member with Alzheimer's disease or other dementia.


Alzheimer's Disease Neuroimaging Initiative - GO
Pre-Mild Cognitive Impariment Study


BAN2401
A 18 month infusion study to slow Alzheimer's disease (AD) progression


EPOCH
A clinical trial testing a new treatment for Alzheimer's disease (AD)


Nerve Growth Factor: Gene Therapy Surgical Intervention Trial

Results pending.

Lewy Body Disease


Cognitive Rehabilitation of Memory in Mild Cognitive Impairment
Examines changes in learning, memory, and brain activity


Cognitive Aging Project


Natural History of FTD Subtypes


Memory Training in Mild Cognitive Impairment

Results pending

Starshine


MK8931-019
2-year trial for treatment of MCI


DHA, an Omega 3 Fatty Acide, in Slowing the Progression of Alzheimer's DiseaseDocosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial


RAGE (Receptor for Advanced Glycation Endproducts) Inhibitor StudyPF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease


Caregiver Opportunities for Optimizing Lifestyles: A Research Opportunity for African American Caregivers (COOL-AD)


Development of a Biomarker for FTLD-TDP and FTLD-Tau


Cognitive Decline in Patients with Amyotrophic Lateral Sclerosis (ALS)


Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
Kurlan R, Cummings J, Raman R, Thal L for the Alzheimer's Disease Cooperative Study Group Neurology. 2007 April 24: 68; 1356-1363


Vitamins to Slow Alzheimer's Disease (Homocysteine Study) (VITAL)High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial


Mild Cognitive Impairment Study Aricept, Vitamin E or PlaceboVitamin E and donepezil for the treatment of mild cognitive impairment.
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group, N Engl J Med. 2005 Jun 9; 352(23):2379-88. Epub 2005 Apr 13


TauRx
1 year study for treatment of bvFTD


The Role of Sleep in Cognitive Decline in Normal Aging


TOMMORROW
5-year prevention trial


VASCULAR
VASCULAR studies the role of circulatory function on memory and the risk of Alzheimer┬┐s disease.